Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/76397
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | De las Cuevas, Natividad | - |
dc.contributor.author | Muñoz, Úrsula | - |
dc.contributor.author | García-Hermida, Ofelia | - |
dc.contributor.author | Martín-Requero, Ángeles | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Neurobiology of Aging, 26: 615-624 (2005) | es_ES |
dc.identifier.issn | 0197-4580 | - |
dc.identifier.uri | http://hdl.handle.net/10261/76397 | - |
dc.description | This work has been supported by grants from the Spanish Fondo de Investigaciones Sanitarias (01/1194), Ministerio de Ciencia y Tecnología (SAF 2003-01458) and the “Fundación Rodríguez Pascual”. N.C. and U.M. are fellows from the Fondo de Investigaciones Sanitarias de la Seguridad Social and Ministerio de Educación y Cultura, respectively | es_ES |
dc.description.abstract | Cell cycle disturbances may precede neuronal death in Alzheimer's disease (AD). We described alterations, in lymphocytes from AD patients, on the activity of two transcription factors, E2F and NF-κB, involved in cell proliferation and survival regulation, demonstrating that cell cycle dysfunction also occurs in peripheral cells. The analysis of E2F–DNA binding activity revealed lower signal intensity of protein–DNA complexes in AD cells, which correlated with increased phosphorylation of retinoblastoma (pRb) related proteins and enhanced proliferation. The calmodulin (CaM) antagonist calmidazolium (CMZ) abrogated the increased activity of AD cells by partially dephosphorylating pRb and p130. The NF-κB–DNA binding activity increased as cell progress through the cell cycle. The reduced NF-κB activation observed in AD cells appears not to be related to the increased phosphorylation of the pRb family proteins nor with the enhanced proliferative activity of AD cells, but seems to protect them from death induced by the loss of trophic support. Ca2+/CaM antagonists rescue NF-κB–DNA binding activity and sensitize AD cells to serum withdrawal. These observations suggest that disruption of Ca2+/CaM signaling pathway could be linked mechanistically to its pro cell survival actions, promoting enhanced proliferation or decreased cell death depending on the presence of growth-stimulatory signals | es_ES |
dc.description.sponsorship | 10 páginas, 7 figuras -- PAGS nros. 615-624 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | closedAccess | es_ES |
dc.subject | Alzheimer's disease | es_ES |
dc.subject | Lymphocytes | es_ES |
dc.subject | Calmodulin | es_ES |
dc.subject | E2F | es_ES |
dc.subject | NF-κB | es_ES |
dc.title | Altered transcriptional regulators in response to serum in immortalized lympozytes from Alzheimer disease patients | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1016/j.neurobiolaging.2004.06.006 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.neurobiolaging.2004.06.006 | es_ES |
dc.identifier.e-issn | 1558-1497 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
24
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
22
checked on 23-feb-2024
Page view(s)
318
checked on 18-abr-2024
Download(s)
100
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.